Vitamin D Metabolites Regulate Matrix Vesicle Metalloproteinase Content in a Cell Maturation-Dependent Manner

David D Dean, B. D. Boyan, O. E. Muniz, D. S. Howell, Zvi Schwartz

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

Matrix vesicles are extracellular organelles produced by cells that mineralize their matrix. They contain enzymes that are associated with calcification and are regulated by vitamin D metabolites in a cell maturation-dependent manner. Matrix vesicles also contain metalloproteinases that degrade proteoglycans, macromolecules known to inhibit calcification in vitro, as well as plasminogen activator, a proteinase postulated to play a role in activation of latent TGF-\. In the present study, we examined whether matrix vesicle metalloproteinase and plasminogen activator are regulated by 1,25(OH)2D3 and 24,25 (OH)2D3. Matrix vesicles and plasma membranes were isolated from fourth passage cultures of resting zone chondrocytes that had been incubated with 1010-10-7 M24,25(OH)2D3 or growth zone chondrocytes incubated with 10-11-l0-8 M 1,25(OH)2D3, and their alkaline phosphatase, active and total neutral metalloproteinase, and plasminogen activator activities determined. 24,25(OH)2D3 increased alkaline phosphatase by 35-60%, decreased active and total metalloproteinase by 75%, and increased plasminogen activator by fivefold in matrix vesicles from resting zone chondrocyte cultures. No effect of vitamin D treatment was observed in plasma membranes isolated from these cultures. In contrast, 1,25(OH)2D3 increased alkaline phosphatase by 35-60%, but increased active and total metalloproteinase three- to fivefold and decreased plasminogen activator by as much as 75% in matrix vesicles isolated from growth zone chondrocyte cultures. Vitamin D treatment had no effect on plasma membrane alkaline phosphatase or metalloproteinase, but decreased plasminogen activator activity. The results demonstrate that neutral metalloproteinase and plasminogen activator activity in matrix vesicles are regulated by vitamin D metabolites in a cell maturation-specific manner. In addition, they support the hypothesis that 1,25(OH)2D3 regulation of matrix vesicle function facilitates calcification by increasing alkaline phosphatase and phospholipase A2 specific activities as well as metalloprotemases which degrade proteoglycans.

Original languageEnglish (US)
Pages (from-to)109-116
Number of pages8
JournalCalcified Tissue International
Volume59
Issue number2
DOIs
StatePublished - Aug 1996

Fingerprint

Plasminogen Activators
Matrix Metalloproteinases
Vitamin D
Metalloproteases
Alkaline Phosphatase
Chondrocytes
Cell Membrane
Proteoglycans
Phospholipases A2
Growth
Organelles
Extracellular Matrix
Peptide Hydrolases
Enzymes

Keywords

  • 1,25(OH)D
  • 24,25(OH)D
  • Calcification
  • Chondrocytes
  • Matrix vesicles
  • Metalloproteinases

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Vitamin D Metabolites Regulate Matrix Vesicle Metalloproteinase Content in a Cell Maturation-Dependent Manner. / Dean, David D; Boyan, B. D.; Muniz, O. E.; Howell, D. S.; Schwartz, Zvi.

In: Calcified Tissue International, Vol. 59, No. 2, 08.1996, p. 109-116.

Research output: Contribution to journalArticle

Dean, David D ; Boyan, B. D. ; Muniz, O. E. ; Howell, D. S. ; Schwartz, Zvi. / Vitamin D Metabolites Regulate Matrix Vesicle Metalloproteinase Content in a Cell Maturation-Dependent Manner. In: Calcified Tissue International. 1996 ; Vol. 59, No. 2. pp. 109-116.
@article{df2a66ba765d49f3bc62994bdcdb21e2,
title = "Vitamin D Metabolites Regulate Matrix Vesicle Metalloproteinase Content in a Cell Maturation-Dependent Manner",
abstract = "Matrix vesicles are extracellular organelles produced by cells that mineralize their matrix. They contain enzymes that are associated with calcification and are regulated by vitamin D metabolites in a cell maturation-dependent manner. Matrix vesicles also contain metalloproteinases that degrade proteoglycans, macromolecules known to inhibit calcification in vitro, as well as plasminogen activator, a proteinase postulated to play a role in activation of latent TGF-\. In the present study, we examined whether matrix vesicle metalloproteinase and plasminogen activator are regulated by 1,25(OH)2D3 and 24,25 (OH)2D3. Matrix vesicles and plasma membranes were isolated from fourth passage cultures of resting zone chondrocytes that had been incubated with 1010-10-7 M24,25(OH)2D3 or growth zone chondrocytes incubated with 10-11-l0-8 M 1,25(OH)2D3, and their alkaline phosphatase, active and total neutral metalloproteinase, and plasminogen activator activities determined. 24,25(OH)2D3 increased alkaline phosphatase by 35-60{\%}, decreased active and total metalloproteinase by 75{\%}, and increased plasminogen activator by fivefold in matrix vesicles from resting zone chondrocyte cultures. No effect of vitamin D treatment was observed in plasma membranes isolated from these cultures. In contrast, 1,25(OH)2D3 increased alkaline phosphatase by 35-60{\%}, but increased active and total metalloproteinase three- to fivefold and decreased plasminogen activator by as much as 75{\%} in matrix vesicles isolated from growth zone chondrocyte cultures. Vitamin D treatment had no effect on plasma membrane alkaline phosphatase or metalloproteinase, but decreased plasminogen activator activity. The results demonstrate that neutral metalloproteinase and plasminogen activator activity in matrix vesicles are regulated by vitamin D metabolites in a cell maturation-specific manner. In addition, they support the hypothesis that 1,25(OH)2D3 regulation of matrix vesicle function facilitates calcification by increasing alkaline phosphatase and phospholipase A2 specific activities as well as metalloprotemases which degrade proteoglycans.",
keywords = "1,25(OH)D, 24,25(OH)D, Calcification, Chondrocytes, Matrix vesicles, Metalloproteinases",
author = "Dean, {David D} and Boyan, {B. D.} and Muniz, {O. E.} and Howell, {D. S.} and Zvi Schwartz",
year = "1996",
month = "8",
doi = "10.1007/s002239900096",
language = "English (US)",
volume = "59",
pages = "109--116",
journal = "Calcified Tissue International",
issn = "0171-967X",
publisher = "Springer New York",
number = "2",

}

TY - JOUR

T1 - Vitamin D Metabolites Regulate Matrix Vesicle Metalloproteinase Content in a Cell Maturation-Dependent Manner

AU - Dean, David D

AU - Boyan, B. D.

AU - Muniz, O. E.

AU - Howell, D. S.

AU - Schwartz, Zvi

PY - 1996/8

Y1 - 1996/8

N2 - Matrix vesicles are extracellular organelles produced by cells that mineralize their matrix. They contain enzymes that are associated with calcification and are regulated by vitamin D metabolites in a cell maturation-dependent manner. Matrix vesicles also contain metalloproteinases that degrade proteoglycans, macromolecules known to inhibit calcification in vitro, as well as plasminogen activator, a proteinase postulated to play a role in activation of latent TGF-\. In the present study, we examined whether matrix vesicle metalloproteinase and plasminogen activator are regulated by 1,25(OH)2D3 and 24,25 (OH)2D3. Matrix vesicles and plasma membranes were isolated from fourth passage cultures of resting zone chondrocytes that had been incubated with 1010-10-7 M24,25(OH)2D3 or growth zone chondrocytes incubated with 10-11-l0-8 M 1,25(OH)2D3, and their alkaline phosphatase, active and total neutral metalloproteinase, and plasminogen activator activities determined. 24,25(OH)2D3 increased alkaline phosphatase by 35-60%, decreased active and total metalloproteinase by 75%, and increased plasminogen activator by fivefold in matrix vesicles from resting zone chondrocyte cultures. No effect of vitamin D treatment was observed in plasma membranes isolated from these cultures. In contrast, 1,25(OH)2D3 increased alkaline phosphatase by 35-60%, but increased active and total metalloproteinase three- to fivefold and decreased plasminogen activator by as much as 75% in matrix vesicles isolated from growth zone chondrocyte cultures. Vitamin D treatment had no effect on plasma membrane alkaline phosphatase or metalloproteinase, but decreased plasminogen activator activity. The results demonstrate that neutral metalloproteinase and plasminogen activator activity in matrix vesicles are regulated by vitamin D metabolites in a cell maturation-specific manner. In addition, they support the hypothesis that 1,25(OH)2D3 regulation of matrix vesicle function facilitates calcification by increasing alkaline phosphatase and phospholipase A2 specific activities as well as metalloprotemases which degrade proteoglycans.

AB - Matrix vesicles are extracellular organelles produced by cells that mineralize their matrix. They contain enzymes that are associated with calcification and are regulated by vitamin D metabolites in a cell maturation-dependent manner. Matrix vesicles also contain metalloproteinases that degrade proteoglycans, macromolecules known to inhibit calcification in vitro, as well as plasminogen activator, a proteinase postulated to play a role in activation of latent TGF-\. In the present study, we examined whether matrix vesicle metalloproteinase and plasminogen activator are regulated by 1,25(OH)2D3 and 24,25 (OH)2D3. Matrix vesicles and plasma membranes were isolated from fourth passage cultures of resting zone chondrocytes that had been incubated with 1010-10-7 M24,25(OH)2D3 or growth zone chondrocytes incubated with 10-11-l0-8 M 1,25(OH)2D3, and their alkaline phosphatase, active and total neutral metalloproteinase, and plasminogen activator activities determined. 24,25(OH)2D3 increased alkaline phosphatase by 35-60%, decreased active and total metalloproteinase by 75%, and increased plasminogen activator by fivefold in matrix vesicles from resting zone chondrocyte cultures. No effect of vitamin D treatment was observed in plasma membranes isolated from these cultures. In contrast, 1,25(OH)2D3 increased alkaline phosphatase by 35-60%, but increased active and total metalloproteinase three- to fivefold and decreased plasminogen activator by as much as 75% in matrix vesicles isolated from growth zone chondrocyte cultures. Vitamin D treatment had no effect on plasma membrane alkaline phosphatase or metalloproteinase, but decreased plasminogen activator activity. The results demonstrate that neutral metalloproteinase and plasminogen activator activity in matrix vesicles are regulated by vitamin D metabolites in a cell maturation-specific manner. In addition, they support the hypothesis that 1,25(OH)2D3 regulation of matrix vesicle function facilitates calcification by increasing alkaline phosphatase and phospholipase A2 specific activities as well as metalloprotemases which degrade proteoglycans.

KW - 1,25(OH)D

KW - 24,25(OH)D

KW - Calcification

KW - Chondrocytes

KW - Matrix vesicles

KW - Metalloproteinases

UR - http://www.scopus.com/inward/record.url?scp=0029812420&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029812420&partnerID=8YFLogxK

U2 - 10.1007/s002239900096

DO - 10.1007/s002239900096

M3 - Article

C2 - 8687979

AN - SCOPUS:0029812420

VL - 59

SP - 109

EP - 116

JO - Calcified Tissue International

JF - Calcified Tissue International

SN - 0171-967X

IS - 2

ER -